N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-2-methyl-4-phenyl-1,3-oxazole-5-carboxamide;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-2-methyl-4-quinoxalin-2-yl-1,3-oxazole-5-carboxamide;N-[(2S)-4-amino-1-(4-hydroxyphenyl)-3,4-dioxobutan-2-yl]-2-methyl-4-phenyl-1,3-oxazole-5-carboxamide;[4-[(2S)-4-amino-2-[(2-methyl-4-phenyl-1,3-oxazole-5-carbonyl)amino]-3,4-dioxobutyl]phenyl] trifluoromethanesulfonate;4-(3-fluorophenyl)-2-methyl-N-[(2S)-1-oxo-3-phenylpropan-2-yl]-1,3-oxazole-5-carboxamide;2-methyl-N-[(2S)-1-oxo-3-phenylpropan-2-yl]-4-phenyl-1,3-oxazole-5-carboxamide
C127H110F4N18O26S — CID 158242627
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-2-methyl-4-phenyl-1,3-oxazole-5-carboxamide;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-2-methyl-4-quinoxalin-2-yl-1,3-oxazole-5-carboxamide;N-[(2S)-4-amino-1-(4-hydroxyphenyl)-3,4-dioxobutan-2-yl]-2-methyl-4-phenyl-1,3-oxazole-5-carboxamide;[4-[(2S)-4-amino-2-[(2-methyl-4-phenyl-1,3-oxazole-5-carbonyl)amino]-3,4-dioxobutyl]phenyl] trifluoromethanesulfonate;4-(3-fluorophenyl)-2-methyl-N-[(2S)-1-oxo-3-phenylpropan-2-yl]-1,3-oxazole-5-carboxamide;2-methyl-N-[(2S)-1-oxo-3-phenylpropan-2-yl]-4-phenyl-1,3-oxazole-5-carboxamide
N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-2-methyl-4-phenyl-1,3-oxazole-5-carboxamide;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-2-methyl-4-quinoxalin-2-yl-1,3-oxazole-5-carboxamide;N-[(2S)-4-amino-1-(4-hydroxyphenyl)-3,4-dioxobutan-2-yl]-2-methyl-4-phenyl-1,3-oxazole-5-carboxamide;[4-[(2S)-4-amino-2-[(2-methyl-4-phenyl-1,3-oxazole-5-carbonyl)amino]-3,4-dioxobutyl]phenyl] trifluoromethanesulfonate;4-(3-fluorophenyl)-2-methyl-N-[(2S)-1-oxo-3-phenylpropan-2-yl]-1,3-oxazole-5-carboxamide;2-methyl-N-[(2S)-1-oxo-3-phenylpropan-2-yl]-4-phenyl-1,3-oxazole-5-carboxamide (PubChem CID 158242627) has the molecular formula C127H110F4N18O26S and a molecular weight of 2412.44 g/mol. Its IUPAC name is N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-2-methyl-4-phenyl-1,3-oxazole-5-carboxamide;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-2-methyl-4-quinoxalin-2-yl-1,3-oxazole-5-carboxamide;N-[(2S)-4-amino-1-(4-hydroxyphenyl)-3,4-dioxobutan-2-yl]-2-methyl-4-phenyl-1,3-oxazole-5-carboxamide;[4-[(2S)-4-amino-2-[(2-methyl-4-phenyl-1,3-oxazole-5-carbonyl)amino]-3,4-dioxobutyl]phenyl] trifluoromethanesulfonate;4-(3-fluorophenyl)-2-methyl-N-[(2S)-1-oxo-3-phenylpropan-2-yl]-1,3-oxazole-5-carboxamide;2-methyl-N-[(2S)-1-oxo-3-phenylpropan-2-yl]-4-phenyl-1,3-oxazole-5-carboxamide.
Molecular Properties
| Compound Name | N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-2-methyl-4-phenyl-1,3-oxazole-5-carboxamide;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-2-methyl-4-quinoxalin-2-yl-1,3-oxazole-5-carboxamide;N-[(2S)-4-amino-1-(4-hydroxyphenyl)-3,4-dioxobutan-2-yl]-2-methyl-4-phenyl-1,3-oxazole-5-carboxamide;[4-[(2S)-4-amino-2-[(2-methyl-4-phenyl-1,3-oxazole-5-carbonyl)amino]-3,4-dioxobutyl]phenyl] trifluoromethanesulfonate;4-(3-fluorophenyl)-2-methyl-N-[(2S)-1-oxo-3-phenylpropan-2-yl]-1,3-oxazole-5-carboxamide;2-methyl-N-[(2S)-1-oxo-3-phenylpropan-2-yl]-4-phenyl-1,3-oxazole-5-carboxamide |
|---|---|
| PubChem CID | 158242627 |
| Molecular Formula | C127H110F4N18O26S |
| Molecular Weight | 2412.44 g/mol |
| Exact Mass | 2410.75 |
| IUPAC Name | N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-2-methyl-4-phenyl-1,3-oxazole-5-carboxamide;N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-2-methyl-4-quinoxalin-2-yl-1,3-oxazole-5-carboxamide;N-[(2S)-4-amino-1-(4-hydroxyphenyl)-3,4-dioxobutan-2-yl]-2-methyl-4-phenyl-1,3-oxazole-5-carboxamide;[4-[(2S)-4-amino-2-[(2-methyl-4-phenyl-1,3-oxazole-5-carbonyl)amino]-3,4-dioxobutyl]phenyl] trifluoromethanesulfonate;4-(3-fluorophenyl)-2-methyl-N-[(2S)-1-oxo-3-phenylpropan-2-yl]-1,3-oxazole-5-carboxamide;2-methyl-N-[(2S)-1-oxo-3-phenylpropan-2-yl]-4-phenyl-1,3-oxazole-5-carboxamide |
| SMILES | Cc1nc(-c2cccc(F)c2)c(C(=O)N[C@H](C=O)Cc2ccccc2)o1.Cc1nc(-c2ccccc2)c(C(=O)NC(Cc2ccccc2)C(=O)C(N)=O)o1.Cc1nc(-c2ccccc2)c(C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)C(N)=O)o1.Cc1nc(-c2ccccc2)c(C(=O)N[C@@H](Cc2ccc(OS(=O)(=O)C(F)(F)F)cc2)C(=O)C(N)=O)o1.Cc1nc(-c2ccccc2)c(C(=O)N[C@H](C=O)Cc2ccccc2)o1.Cc1nc(-c2cnc3ccccc3n2)c(C(=O)NC(Cc2ccccc2)C(=O)C(N)=O)o1 |
| InChI | InChI=1S/C23H19N5O4.C22H18F3N3O7S.C21H19N3O5.C21H19N3O4.C20H17FN2O3.C20H18N2O3/c1-13-26-19(18-12-25-15-9-5-6-10-16(15)27-18)21(32-13)23(31)28-17(20(29)22(24)30)11-14-7-3-2-4-8-14;1-12-27-17(14-5-3-2-4-6-14)19(34-12)21(31)28-16(18(29)20(26)30)11-13-7-9-15(10-8-13)35-36(32,33)22(23,24)25;1-12-23-17(14-5-3-2-4-6-14)19(29-12)21(28)24-16(18(26)20(22)27)11-13-7-9-15(25)10-8-13;1-13-23-17(15-10-6-3-7-11-15)19(28-13)21(27)24-16(18(25)20(22)26)12-14-8-4-2-5-9-14;1-13-22-18(15-8-5-9-16(21)11-15)19(26-13)20(25)23-17(12-24)10-14-6-3-2-4-7-14;1-14-21-18(16-10-6-3-7-11-16)19(25-14)20(24)22-17(13-23)12-15-8-4-2-5-9-15/h2-10,12,17H,11H2,1H3,(H2,24,30)(H,28,31);2-10,16H,11H2,1H3,(H2,26,30)(H,28,31);2-10,16,25H,11H2,1H3,(H2,22,27)(H,24,28);2-11,16H,12H2,1H3,(H2,22,26)(H,24,27);2-9,11-12,17H,10H2,1H3,(H,23,25);2-11,13,17H,12H2,1H3,(H,22,24)/t;2*16-;;2*17-/m.00.00/s1 |
| InChIKey | GFSQOGJDFCTNAN-BQCVSJQWSA-N |
| XLogP | 14.58 |
| TPSA | 694.94 Ų |
| H-Bond Donors | 11 |
| H-Bond Acceptors | 34 |
| Rotatable Bonds | 42 |
| Heavy Atoms | 176 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2412.44 |
| LogP ≤ 5 | 14.58 |
| H-Bond Donors ≤ 5 | 11 |
| H-Bond Acceptors ≤ 10 | 34 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'diketo_group', 'substructure': 'N/A'}, {'alert_name': 'Sulfonic_acid_1', 'substructure': 'N/A'}, {'alert_name': 'triflate', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158242627 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.